NSETrading Window24 Jun 2026 · 24 Jun 2026, 11:09 am

Trading Window

Aarti Pharmalabs Limited · AARTIPHARM

✦ AI Summary

Aarti Pharmalabs Limited has closed its trading window for dealing in its securities from July 1, 2026, until 48 hours after the declaration of its financial results for the quarter ending June 30, 2026.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Aarti Pharmalabs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

AARTIPHARMA_24062026110923_APL_Window_Closure_March_2026signed.pdf

pdf

Download →
View document text
June 24, 2026 To, To, Listing/ Compliance Department Listing/ Compliance Department BSE LTD. National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1, Dalal Street, G Block, Bandra Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai – 400 051 SCRIP CODE: 543748 SYMBOL: AARTIPHARM Dear Sir/Madam, Sub: Closure of Trading Window Ref: SEBI (Prohibition of Insider Trading) Regulations, 2015 Pursuant to Company’s Code Prohibition of Insider Trading framed pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and amendments thereunder, the trading window for dealing in the securities of the Company will remain closed from Wednesday, July 01, 2026 till 48 hours after the declaration of Financial Results of the Company for the quarter ending on June 30, 2026. The same has also been intimated to all the Designated Persons/Connected Persons of the Company. The date of the Board Meeting in which the said results will be considered for approval, will be informed in due course. Please take note of the above on your record. Thanking you, Yours faithfully, For AARTI PHARMALABS LIMITED JEEVAN MONDKAR COMPANY SECRETARY AND LEGAL HEAD ICSI M. NO. A22565